Β-lactam allergy: Difference between revisions

From IDWiki
Β-lactam allergy
No edit summary
No edit summary
Line 3: Line 3:
==Cross-Reactivity==
==Cross-Reactivity==


* Cross-reactivity between [[penicillins]] and [[cephalosporins]] is mediated by homology of the R1 side chains, referring to the C6 side chain in [[penicillins]] or the C7 side chain in [[cephalosporins]]
*Cross-reactivity between [[penicillins]] and [[cephalosporins]] is mediated by homology of the R1 side chains, referring to the C6 side chain in [[penicillins]] or the C7 side chain in [[cephalosporins]]
* Cross-reactivity within [[cephalosporins]] is mediated both by homology of the R1 side chains and also R2 side chains, referring to the C3 side chain
*Cross-reactivity within [[cephalosporins]] is mediated both by homology of the R1 side chains and also R2 side chains, referring to the C3 side chain


{| class="wikitable"
{| class="wikitable"
Line 21: Line 21:
!G6
!G6
!G7
!G7
|-
! colspan="11" |Penicillins
|-
|-
|[[Penicillin]]
|[[Penicillin]]
Line 57: Line 59:
| align="center" |
| align="center" |
| align="center" |
| align="center" |
|-
! colspan="11" |First-Generation Cephalosporins
|-
|-
|[[Cefazolin]]
|[[Cefazolin]]
Line 105: Line 109:
| align="center" |
| align="center" |
| align="center" |
| align="center" |
|-
! colspan="11" |Second-Generation Cephalosporins
|-
|-
|[[Cefotetan]]
|[[Cefotetan]]
Line 153: Line 159:
| align="center" |
| align="center" |
| align="center" |
| align="center" |
|-
! colspan="11" |Third-Generation Cephalosporins
|-
|-
|[[Cefotaxime]]
|[[Cefotaxime]]
Line 213: Line 221:
| align="center" |
| align="center" |
| align="center" |
| align="center" |
|-
! colspan="11" |Fourth-Generation Cephalosporins and Higher
|-
|-
|[[Cefipime]]
|[[Cefipime]]
Line 241: Line 251:
===R1 Side Chains (C6 and C7)===
===R1 Side Chains (C6 and C7)===


*'''Group 1:''' [[penicillin]], [[cephalothin]], [[cefoxitin]]
*'''Group 1:''' [[penicillin]], [[cephalothin]], [[cefoxitin]]; similar to [[ticarcillin]]
*'''Group 2:''' [[amoxicillin]], [[ampicillin]], [[cefaclor]], [[cephalexin]], [[cefadroxil]]
*'''Group 2:''' [[amoxicillin]], [[ampicillin]], [[cefaclor]], [[cephalexin]], [[cefadroxil]]; similar to [[penicillin]] [[piperacillin]]
*'''Group 3:''' [[cefipime]], [[cefotaxime]], [[ceftriaxone]]
*'''Group 3:''' [[cefipime]], [[cefotaxime]], [[ceftriaxone]]; similar to [[ceftazidime]] and [[aztreonam]]
*[[Ceftazidime]] and [[aztreonam]]; similar to group 3


===R2 Side Chains (C3)===
===R2 Side Chains (C3)===

Revision as of 14:22, 16 September 2020


Cross-Reactivity

  • Cross-reactivity between penicillins and cephalosporins is mediated by homology of the R1 side chains, referring to the C6 side chain in penicillins or the C7 side chain in cephalosporins
  • Cross-reactivity within cephalosporins is mediated both by homology of the R1 side chains and also R2 side chains, referring to the C3 side chain
Antibiotic R1 R2
G1 G2 G3 G1 G2 G3 G4 G5 G6 G7
Penicillins
Penicillin X
Ampicillin X
Amoxicillin X
First-Generation Cephalosporins
Cefazolin
Cephalexin X X
Cefadroxil X X
Cephalothin X X
Second-Generation Cephalosporins
Cefotetan X
Cefoxitin X X
Cefuroxime X
Cefaclor X
Third-Generation Cephalosporins
Cefotaxime X X
Ceftriaxone X
Ceftazidime X
Cefixime X
Cefdinir
Fourth-Generation Cephalosporins and Higher
Cefipime X
Ceftaroline

R1 Side Chains (C6 and C7)

R2 Side Chains (C3)

Hypersensitivity Reactions

  • Type I (IgE-mediated)
    • Anaphylaxis
    • Itchy rash
    • Penicillins should be avoided
  • Type II (IgG-mediated)
    • Non-itchy rash
    • Rash will improve if treatment continues, no need to avoid penicillins
  • Type IV (cell-mediated)
    • Toxic epidermal necrolysis
    • Stevens-Johnson syndrome
    • Penicillins should be avoided

Further Reading

  • Zagursky RJ and Pichichero ME. Cross-reactivity in β-Lactam Allergy. J Allergy Clin Immunol Pract. 2018;6(1):72-81.e1. doi: 10.1016/j.jaip.2017.08.027

References

  1. ^  Brittany Kula, Gordana Djordjevic, Joan L. Robinson. A Systematic Review: Can One Prescribe Carbapenems to Patients With IgE-Mediated Allergy to Penicillins or Cephalosporins?. Clinical Infectious Diseases. 2014;59(8):1113-1122. doi:10.1093/cid/ciu587.